Wound Care Resources

Wound dressing selection should reflect wound management objectives and be integrated into the overall management plan. Volume of exudate will impact greatly on that decision-making process. This article focuses on what causes excess exudate, assessing exudate and its subsequent management. It concludes by introducing Biatain  Fiber with HexaLock  Technology, a dressing which is used to address clinical challenges of managing wounds which are producing a moderate-to-high volume of exudate.

Ulceration of the lower limbs can be a painful, debilitating condition which may have a profound effect on the patient physically, psychologically, and socially. With an ageing population, it is likely that we will see greater numbers of patients suffering with chronic wounds and associated skin conditions in the coming years. Where there are variations in care, and sub-optimal treatment regimens, delayed healing may be both common and costly to the NHS. National programmes have been put in place to address these inequities, however all clinicians are integral in the management of patients with wounds to ensure that accurate assessment takes place, both on initial contact and opportunistically throughout the care period. Following assessment, appropriate treatment plans should be implemented, preventing further skin breakdown, and improving outcomes for the patient and healthcare system.

This case series evaluation assessed the efficacy of WoundExpress™ (Huntleigh Healthcare), a novel IPC device, which applies compression to the thigh of the afflicted leg for the management of hard-to-heal leg ulcers. Eleven wound treatment centres or wound care specialists undertook WoundExpress evaluations. Eligible and willing patients (n=61), with a ‘hard-to heal’ leg ulcer used the WoundExpress device for two hours a day, in addition to continuing to receive their standard wound care for a 16-week period. Fifty-three participants completed the evaluations. Thirty-three percent (n=19) of all ulcers healed within the 16-week study period; the mean time to healing was 10 weeks. A further 60% of ulcers (n=35) progressed towards healing within the 16-week period, with a mean surface area reduction of 56% (23cm2). The evaluation concluded that thigh-administered IPC is an effective adjunctive treatment, that aids healing and reduces pain, for patients with hard to heal leg ulcers.